好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Cognitive Subscale of The Modified Fatigue Impact Scale is not Correlated with Verbal Learning and Memory in Multiple Sclerosis
Multiple Sclerosis
MS and CNS Inflammatory Disease Posters (7:00 AM-5:00 PM)
040

To examine the relationship between the cognitive subscale of the modified fatigue impact scale (MFIS-CS) and objective measures of cognition in patients with multiple sclerosis (MS).

MFIS is a validated instrument for assessment of severity of fatigue in MS; it is composed of 21 questions which span physical, cognitive and psychosocial domains. However, it remains to be determined if impairment in MFIS-CS actually correlates with objective impairments in cognition.

Fifty-four participants (20M/34F) were recruited as part of an intervention for cognitive impairment in MS. Mean age of the subjects was 43.64 years, (SD=9.77), mean education was 15.21 years (SD=2.19), and a mean EDSS step score was 3.78 (SD=1.99). Participants underwent testing with the Symbol Digit Modalities Test (SDMT), California Verbal Learning Test II (CVLT-II), and Beck Depression Inventory (BDI). Correlation with MFIS-CS was analyzed using the Pearson Correlation Coefficient in SPSS.  

Pearson correlation analyses revealed no significant relationship between MFIS-CS and SDMT (r(52) = .02, p= .88) or CVLT-II learning (trials 1-5) (r(52) = .02, p = .87). However, a significant correlation was observed between MFIS-CS and BDI-II scores (r(52) = .44, p < .001). 

These results indicate a discordance between reported cognitive fatigue and objective measures of cognitive performance in MS patients. Moreover, the correlation of the MFIS-CS with depressive symptoms is consistent with previous reports that depression may be underlying perceptions of cognitive impairment in MS patients. These findings underscore the relevance of interpreting both subjective and objective reports of patients with MS as well as their emotional status in relation to problems with fatigue. 

Authors/Disclosures
Steven H. Lang
PRESENTER
Mr. Lang has nothing to disclose.
Heather Katzen, PhD Dr. Katzen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Adult Hydrocephalus Clinical Research Network. Dr. Katzen has received publishing royalties from a publication relating to health care.
Leticia Tornes, MD, FAAN (University of Miami) Dr. Tornes has nothing to disclose.
Melissa R. Ortega, MD (University of Miami) An immediate family member of Dr. Ortega has received personal compensation for serving as an employee of Aptitude. An immediate family member of Dr. Ortega has received personal compensation for serving as an employee of Oncocyte. An immediate family member of Dr. Ortega has received personal compensation for serving as an employee of Total Health Information.
No disclosure on file
Kottil W. Rammohan, MD (University of Miami) Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. The institution of Dr. Rammohan has received research support from Genentech. The institution of Dr. Rammohan has received research support from Genzyme. The institution of Dr. Rammohan has received research support from EMD Serono. The institution of Dr. Rammohan has received research support from Alexion.
Annelly Buré-Reyes Annelly Buré-Reyes has nothing to disclose.